Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronized progesterone versus progesterone suppository for threatened abortion
IRCT20120104008611N9Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of progesterone in threatened abortion (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Pregnancy continuation, Preterm delivery and 1 more. Started Feb 2022; status: completed.
02
Drugs
progesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on IRCT20120104008611N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120104008611N9.